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Abstract 
Diabetes is the most devastating and serious of all metabolic diseases. The available natural 
remedies are considered as a valuable source of therapeutic agents. A scientific validation of 
the reported antidiabetic plants on the basis of their traditional use may pave the way for the 
development of novel and effective antidiabetic drugs. Such approaches are the necessity of 
the day because the available medicines are insufficient to manage all the consequences of 
diabetes, and the economic problems and a shortage of current therapies in most developing 
countries. This review comprises information about antidiabetic medicinal plants of Pakistan 
with respect to traditional knowledge. The article also includes the in-vitro or in-vivo potential, 
toxicity, mode of action, and perspective for future research. This effort may serve as a 
leading point for the formulation of novel herbal mixtures, development of antidiabetic drugs or 
their precursors. 
Keywords: Antidiabetic medicinal plants; traditional knowledge; pharmacological validation. 
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INTRODUCTION 
Diabetes describes a group of chronic metabolic 
disorders characterized by hyperglycemia resulting from 
defects in insulin secretion, insulin action or both 
(Ogurtsova et al., 2017; Ortiz-Andrade et al., 2005). It also 
leads to hyperlipidemia, atherosclerosis, and hypertension 
(Luo et al., 2004) dysfunction and failure of various organs 
(Brunton, 2009) blindness, kidney failure, lower limb 
amputation, dementia and some forms of cancer 
(Federation, 2013; Organization, 2016). A World Health 
Organization (WHO) report indicates that diabetes will be 
the seventh leading cause of death in 2030 (Mathers and 
Loncar, 2006; Wild et al., 2004). The International Diabetes 
Federation (IDF) estimated that in 2013, 382 million people 
had diabetes worldwide and that this figure would rise to 
592 million by 2035 (Federation, 2013). Out of this, a huge 
number, 80%, live in low and middle-income countries, with 
more than 60% living in Asia and nearly one-third in China. 
A study reported the prevalence of diabetes to be 34.80%, 
prevalence in women was calculated to be 31.20% and in 
males 40.40% (Muhammad et al., 2013). The incidence of 
diabetes is higher in developing countries due to quick and 
ongoing socioeconomic transition; this factor will likely lead 
to further rises in the disease (Guariguata et al., 2014). The 
IDF estimates that the number of people with diabetes in 
South Asia will increase to 120.9 million, 10.2% of the adult 
population, by 2030 (Whiting et al., 2011). India with more 
than 65.1 million diabetic people is the second country next 
to China in the IDF global list of top 10 countries for people 
with diabetes. According to an IDF report of (2014), 
Pakistan and Bangladesh also have large numbers of 
people with diabetes and occupy 12th and 13th positions, 
respectively (Nanditha et al., 2016). However, in developed 
countries as in  China (20.8%)  and  USA  (17.7%), the 
occurrence and consequences associated with diabetes 
are also high, and that that may rise up to 42.3% and 
30.3% by 2030, respectively (Wild et al., 2004). 
Diabetes is of three types: type 1 or insulin-dependent, 
type 2 or non–insulin dependent and gestational diabetes. 
In Type 1 diabetes, the body produces inadequate insulin 
to regulate the level of glucose in the blood. This leads to 
excessive urination, constant hunger, thirst, vision changes, 
weight loss, and fatigue. In such cases, insulin is provided 
to the patient for survival. Its cause is still not identified and 
is therefore not preventable. In Type 2 diabetes the body is 
unable to use efficiently insulin released from the pancreas. 
The majority of diabetic people are affected by type 2 - that 
accounts for 90%–95% of all diabetic cases. This shows 
similar symptoms to type 1 but is less noticeable and may 
go undiagnosed for several years until complications have 
already arisen. Gestational diabetes is characterized by 
high blood glucose levels that occur due to hormonal 
changes during pregnancy in genetically predisposed 
individuals. It is more common among obese women and 
women with a family history of diabetes. It usually is 
resolved once the baby is born. However, after pregnancy, 
5% - 10% of women with gestational diabetes are found to 
have type 2 diabetes. 
Currently, large amounts of antidiabetic medicines are 
available in the pharmaceutical market used for the 
treatment of diabetes and its related complications. These 
antidiabetic medicines are; biguanides e.g., metformin, 
which increases cellular responses to insulin and reduces 
the amount of glucose released by the liver into the blood. 
Sulphonylureas increase pancreatic insulin secretion e. g, 
chlorpropamide, glimepiride, glipizide, and glyburide. 
Glitazones, or thiazolidinediones, e. g., pioglitazone and 
rosiglitazone enhance the effect of insulin in the muscle 
and fat and reduce glucose production by the liver. Alpha-
glucosidase inhibitors e. g., acarbose and miglitol inhibit the 
activity of intestinal enzymes responsible for the breakdown 
of polysaccharides into glucose, hence, reducing the 
amount of glucose absorbed in the gut. Dipeptidyl 
peptidase-4 (DPP4) inhibitors have multiple effects, 
including increases in pancreatic insulin secretion, 
examples of such drugs are, alogliptin, linagliptin, and 
saxagliptin. Sodium-glucose co-transporter 2 (SGLT2) 
inhibitors include canagliflozin and dapagliflozin inhibiting 
the re-absorption of glucose in the kidneys. Meglitinides e. 
g., repaglinide and nateglinide, also stimulate insulin 
secretion. In spite of the use of these antidiabetic 
medicines, there is no effective therapy available to 
completely cure the disease. The available antidiabetic 
medicines are effective in some way but managing 
diabetes through the use of the available antidiabetic 
medicines without any side effects is still a challenge (Lo 
and Wasser, 2011). Thus, alternative therapy from the 
herbal origin is required in this shift towards the indigenous 
plants and herbal formulations. 
Traditional use of plants is gaining reputation as an 
alternative to provide a sound base for evaluation of 
antidiabetic crude extracts, isolation of active constituents 
and herbal formulation. Around the world, over 1200 plants 
species have been reported to be used for the treatment of 
diabetes (Grover et al., 2002; Marles and Farnsworth, 
1995). In developing countries, such practices are common 
where people used medicinal plants for a long time, these 
plants had a hypoglycemic potential to alleviate the 
symptoms of diabetes (Ernst, 1997). The remedies and 
antidiabetic agents obtained from these plants on account 
of their pharmacological effects reverse diabetic 
consequences. They may enhance release of insulin from 
ᵦ-cell (Eddouks et al., 2005) or restore the number of ᵦ-
cells. Some plants show their antidiabetic effect by lowering 
absorption or transport of carbohydrates in order to 
maintain blood glucose levels. Some other plants slow 
down the synthesis of glucose by inhibiting enzymes like 
glucose-6-phosphatase, fructose 1, 6-bisphosphatase, etc. 
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Besides these, the antioxidant potential of plants can treat 
the symptoms of diabetes. Therefore, it is now essential to 
explore the potentials offered by the traditional medicinal 
plants through integrated approaches toward the 
management and prevention of diabetes. This review was 
initiated with the aim of compiling traditional antidiabetic 
plants, associated traditional knowledge, their efficacy, 
limitations, and, with a view to further investigation. Thus, 
the information provided may be helpful to health 
practitioners, pharmacologists and researchers.  
 
Methodology  
A literature search was made to collect information on 
the plants from electronic databases, Google Scholar, 
Scopus, Pub Med and Science Direct with key terms; 
ethnomedicinal plants, antidiabetic, hypoglycemic and 
hyperglycemic potential published until May 2017. Scientific 
names and family names of the reported plants were 
confirmed from taxonomic literature. 
 
Ethnobotanical studies, indigenous 
knowledge, and diversity of antidiabetic 
plants in Pakistan 
Indigenous use of medicinal plants has been 
documented in ethno botanical surveys from various parts 
of Pakistan. These surveys show that people residing in 
rural areas usually depend on the available medicinal 
plants for diseases treatment due to limited or inaccessible 
health facilities. The greater use of medicinal plants can 
also be linked to poor economic conditions, cultural 
preference and easy accessibility to natural resources. Out 
of 5700 available medicinal plants in Pakistan (Ahmad and 
Husain, 2008), several plants have been reportedly used 
for the treatment of serious disorders like cancer, diabetes, 
hepatitis, and malaria. Among these, several reports lack 
supporting information like part used formulation methods, 
time and duration of use of remedies, dose, and gender. 
According to (Albuquerque et al., 2014) a huge amount of 
data have been collected through ethnopharmacological 
surveys performed worldwide, much of the collected data 
found being not adequately sound for bio-prospecting 
purposes both from a pharmacological point of view and in 
the data collection of ethnopharmacological surveys. As, 
improper remedies, dosage, harmful side-effects and 
ambiguous products create a potential risk if not 
administered appropriately (Robinson and Zhang, 2011). 
Unfortunately, such information was also not collected for 
some traditional antidiabetic plants in Pakistan. 
Furthermore, the literature search indicates that there is a 
single ethnobotanical study from the district of Attock in 
Pakistan (Ahmad, 2009), that focuses only on medicinal 
plants used against diabetes. 
Ethnomedicinal plants used in the treatment of 
diabetes in Pakistan include 185 plants species belonging 
to 70 families. Among these 70 families are; Asteraceae 
with (16 species) was prominent, followed by Fabaceae (15 
species), Lamiaceae (8 species), Solanaceae (7 species), 
Cucurbitaceous (7 species), Moraceae (7 species), 
Rhamnaceae (6 species), Zygophyllaceae (6 species), 
Myrtaceae (5 species), Euphorbiaceous  (5 species) and 
Rosaceae (5 species). Three families with four species 
each were; Asclepiadaceae, Meliaceae, and Polygonaceae 
and 10 families with three species each was; Apiaceae, 
Apocynaceae, Berberidaceae, Gentianaceae, Liliaceae, 
Malvaceae, Mimosaceae, Oleaceae, Poaceae, and 
Rutaceae. Among the other families, 9 families each 
contributed two species were; Adiantaceae, Alliaceae, 
Bignoniaceae, Brassicaceae, Cactaceae, Capparidaceae, 
Elaeagnaceae, Pinaceae, and Scrophulariaceae. The 
remaining (37) families each contributed single species. On 
the basis of life form habit herbs (105 species) (57. 06%) 
were found frequently used followed by trees (57 species) 
(31.67%) and shrubs (22 species) (12.22%). A few plant 
species were found to be used traditionally in other 
countries for the same purpose. This indicates that their 
traditional knowledge has either originated through ethnic 
links or acquired independently over time. 
A few of the plants have been reported in many 
research articles that indicate the familiarity of these plants 
among various societies in Pakistan for treatment of 
diabetes. These also include important antidiabetic plants 
which have been confirmed and employed in isolated 
bioactive constituents. The mostly reported plants include 
six plants; Hedera nepalensis, Caralluma tuberculata, 
Berberis lycium, Melia azedarach, Syzygium cumini, 
Momordica charantia reported in (14), (12), (10), (9), (9) 
and (6) publications, respectively. Four plants reported in 
(6) publications each include; Citrullus colocynthis, Fagonia 
cretica, Fumaria indica and Taraxacum officinale and two 
plants reported in (5) publications each is; Kickxia 
ramosissima and Ziziphus jujuba. In the other plants,(9) 
species Allium cepa, Catharanthus roseus, Cuscuta 
reflexa, Morus alba, Rhazya stricta, Solanum nigrum, 
Withania coagulans, Zizyphus oxyphyla and Justicia 
adhatoda each has been reported in (4) publications. 
Nineteen plants; Acacia nilotica, Ajuga bracteosa, Allium 
sativum, Aloe barbadensis, Artemisia parvifolia, 
Azadirachta indica, Bergenia ciliata, Caralluma edulis, 
Euphorbia thymifolia, Juniperusexcelsa, Olea ferruginea, 
Punica granatum, Solanum surattense, Teucrium 
stocksianum, Trigonella foenum-graecum, Withania 
somnifera, Ziziphus mauritiana, Ziziphus nummularia and 
Zizyphus sativa each one has three citations. Such higher 
use of plants among various societies may be linked to 
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their wide distribution and medicinal value. Various plants 
were evaluated for the antibacterial activity (Shahzad et al., 
2017). However, some plant species, due to their limited 
distribution in some parts of Pakistan, have been 
documented in the ethnobotanical studies conducted in 
these areas. 
It is essential to confirm which plant parts are used in 
the preparation of remedies because the active chemical 
ingredients vary within plant parts (George, 2000). Among 
the plant parts, leaves (75 species) have been reported as 
mostly used in the formulation of remedies followed by 
whole plants (61species), fruit (43 species), seeds (34 
species), root (22 species), stem (13species), bark 
(13species),flower (10species) shoot (7species), aerial 
parts (6species), gum (5species), latex (3species), wood 
(3species), bulb (2species) and rhizome (1species). 
However, in traditional therapies, the whole plant is rarely 
used for medicine, as one part of those plants may be quite 
toxic or useless, and another may be quite harmless and 
useful (Karunamoorthi, 2013). Therefore, a systematic 
survey of the traditional plants is essential to document 
valuable information for pharmacological and clinical 
investigations in order to discover their antidiabetic 
potential. 
 
Scientific validation of the traditional 
antidiabetic plants of Pakistan 
Among the reported antidiabetic plants from Pakistan, 
several plants have been investigated pharmacologically 
across the globe for their antidiabetic properties. Among 
these pharmacological studies, (36) research studies have 
been conducted on the basis of the traditional use of plants. 
In all these studies, researchers have confirmed their 
traditional antidiabetic use, with 63% studies (Saltan et al., 
2017; Upadhya et al., 2004) that gave positive results and 
have shown significant antidiabetic properties. This shows 
that traditional remedies may provide a better opportunity 
for the discovery of new and effective antidiabetic agents. 
Among the other pharmacological studies with random 
selection, several plants species have shown significant 
antidiabetic properties. No negative result has been 
reported for any of the randomly selected plants. The 
greatest variety of the plants has provided the prospect to 
find new active constituents and mechanisms on a 
chemotaxonomic basis. Alongside this, the quantity and 
effectiveness of plant constituents vary according to 
geographic regions and are influenced by various factors 
including seasons, environment, plant part, intra-species 
variation, and plant age (Weenen et al., 1990). Therefore, 
further evaluation is necessary to assess their antidiabetic 
potential, bioactive constituents and to establish their 
efficacy for better health opportunities.  
Currently used approaches to bioassay-guided 
antidiabetic drug discovery can be divided into two main 
classes: in vivo and in vitro techniques. The 
pharmacological studies conducted for the reported plants 
include (155) in vivo studies and (25) in vitro studies. Only 
five clinical studies have been conducted by researchers. 
In the in vivo studies, diabetes is mostly induced in animal 
models, which is considered as suitable methods for the 
evaluation of physiological and biochemical parameters in 
diabetic conditions. In most of these studies, the 
hyperglycemic condition is created with significant changes 
in insulin levels, lipids metabolism, and oxidative enzymes. 
The liver and kidneys are severely affected, as these 
organs synthesize lipids and proteins and regulate glucose 
levels in the blood. Later, such alterations lead to 
hyperlipidemia and vascular problems. Therefore, rodents, 
including mice, rats, and rabbits are a suitable and 
commonly used model for investigation of in vivo 
antidiabetic properties of plants. In the current review of the 
antidiabetic potential of the reported ethnomedicinal plants, 
researchers have used rats in (130), mice in (24) and 
rabbits in (8) studies. Most researchers experimented on 
the rats, which are the preferred models. In the in vivo 
investigation, researchers have used two main diabetes 
inducing agents; alloxan in (54) studies and streptozotocin 
in (73) studies of the reported plants. In four research 
studies, nicotinamide had been used with streptozotocin. In 
some experiments, the antidiabetic potential of plants had 
been determined in normal (7), glucose-loaded (18), 
genetically (4) and insulin resistant animal models (1).  
Fortunately, in most of the pharmacological studies, 
researchers have used aqueous extract in (57) and 
ethanolic extract in (30) studies. Both these solvents are 
acceptable and commonly used in traditional medicinal 
preparations. In some studies, researchers have used raw 
plant materials in the form of juice, latex or powder 
(Akinmoladun and Akinloye, 2007; Waheed et al., 2007). 
However, a literature search on the pharmacology of 
antidiabetic plants indicates that researchers have used 
other solvents such as benzene, chloroform, 
dichloromethane, ethyl acetate, methanol, methylene 
chloride and petroleum ether. Therefore, the use of such 
solvents in preparation of extract for pharmacological 
investigation is not according to the indigenous methods of 
preparation of plant extracts. Such investigation of plants 
may affect the results obtained. However, a complication 
has been observed in case of Gentiana olivieri, being 
traditionally used as the antidiabetic agent. No effect was 
observed for aqueous extract of aerial parts, while its 
methanolic extract has shown significant activity in glucose-
hyperglycemic rats within 2h (Sezik et al., 2005). In a single 
in vivo study on antihyperglycemic activity of Foeniculum 
vulgare, essential oil blood glucose levels had decreased 
from 162.5 ± 3.19 mg/dl to 81.97 ± 1.97 mg/dl; it also 
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improved the pathological changes noticed in kidney and 
pancreas of STZ induced diabetic rats. 
Few studies suggested higher doses that may not be 
of practical use, e. g., the aqueous extract of Withania 
coagulans had shown a maximum fall of 33.2% in FBG 
after 4h at a dose 1000mg/kg, and a dose of 1000 mg/kg 
reduced the FBG levels by 52.9% on 30
th
 day comparable 
to glipizide at 49.2%. Similarly, a higher dose of 1000 
mg/kg of Vernonia cinerea barks and leaves methanolic 
extract has significantly (p < 0.05) decreased BGL after 
3hrs in alloxan induce rats. Alongside this, few studies 
report the administration of extract by intra-peritoneal route 
(Bhowmik et al., 2009). A recent study on the hypoglycemic 
activity of Cissampelos pareira (Piero et al., 2015) also 
confirmed that the extract administration with the 
intraperitoneal route is more effective than the oral route. 
(Eddouks and Maghrani, 2004) found that Fraxinus 
excelsior seeds aqueous extract 10 mg/kg/h administered 
intravenously, produce a significant decrease in blood 
glucose levels in normal rats (P < 0.001) - even more than 
standard Vanadate (0.8/kg/h) in diabetic rats (P < 0.001). 
Such routes of administration of extract are not employed 
in the traditional therapy of herbal medicines but they may 
be helpful to determine the effectiveness of plant extract in 
reversing diabetic consequences because, in oral 
administration, the extract passes through the gut before 
being absorbed into the blood. A report on the antidiabetic 
potential of Justicia adhatoda L. has been published in a  
banned journal, African Journal of Biotechnology (Gulfraz 
et al., 2011). 
The antidiabetic potential of the reported plants in the 
pharmacological study was recognized by their potentials 
as; hypoglycemic or antihyperglycemic agent which 
enhanced insulin production and restored pancreatic β-cell 
mass (Sebbagh et al., 2009), decreasing HbA1c (Huseini 
et al., 2009), creatinine, urea, cholesterol, triglycerides, low-
density lipoprotein cholesterol, very low-density lipoprotein-
cholesterol and increasing in high-density lipoprotein, 
decreasing effects on LPO, SOD and GSH activity (Omara 
et al., 2012). Besides these, there was a reduction of β-
thromboglobulin and platelet aggregation (Asad et al., 
2011), decreases in MDA levels (Upadhya et al., 2004), 
and free radicals and bilirubin in plasma (El-Demerdash et 
al., 2005), properties of serum enzymes like alkaline 
phosphatase, acid phosphatase and lactate 
dehydrogenase and liver glucose-6-phosphatase (Sheela 
and Augusti, 1992), TBARs level, HOMA_IR, ASAT, 
ALAT,GGT, serum oxaloacetate transaminases, pyruvate 
transaminases, (SGPT) content (Wani et al., 2011) and 
inhibition of protein tyrosine phosphatase1B (Oh et al., 
2005). These plants also improve body weight, total 
proteins, albumin, globulin (Helal et al., 2014), muscle and 
liver glycogen contents. In the in vitro investigation, the 
inhibition of dipeptidyl peptidase IV activity (Yogisha and 
Raveesha, 2010), glucose uptake by hemi-diaphragm,α-
amylase and α-glucosidase and enhancement of glucose 
transport into L6 myotubes (Ahmed et al., 2004) had been 
noticed. Several researchers have observed that plant 
extracts also decrease the oxidative stress of diabetes-
inducing agents in rodent models. Alongside this, diabetes-
induced sexual disability can be corrected through the 
extract of Orchislatifolia. This indicates that traditional 
antidiabetic plants in various ways restore metabolic and 
structural changes that usually arise in diabetes. 
Some plant extracts enhance secretion of insulin from 
pancreas e.g., Albizzia lebbeck, Ailanthus altissima, Allium 
sativum, Arctium lappa, Argyrolobium roseum, Artemisia 
annua, Azadirachta indica, Butea monosperma, Caralluma 
tuberculata, Catharanthus roseus, Citrullus colocynthis, 
Cucurbita maxima, Dalbergia sissoo, Eriobotrya japonica, 
Ficus bengalensis, Fraxinus excelsior, Luffa acutangula, 
Moringa oleifera, Morus alba, Nerium oleander, Olea 
europaea and Ricinus communis have been confirmed as 
insulin tropic agents. In the other studies, a few plant 
fractions or constituents have been confirmed as increasing 
insulin secretion or insulin tolerance. The polyphenol-rich 
gel extract of Aloe vera containing aloin (181.7 mg/g) and 
aloe-emodin (3.6 mg/g) has improved insulin tolerance in 
insulin-resistant mice (Pérez et al., 2007). The butanolic 
fraction of Argyrolobium roseum has stimulated insulin 
secretion in the in vitro (RINm5F cells) and in vivo model 
(Ahmed et al., 2008). Similarly, benzyl derivatives isolated 
from the methanol extract of the Moringa oleifera fruit has 
stimulated insulin secretion from the pancreatic β-cell line 
INS-1. The polysaccharide-Ia isolated from Opuntia dillenii 
protects the liver from peroxidation and improves the 
sensitivity of target cells in diabetic mice to insulin (Zhao et 
al., 2011). 
Only two studies (Ebong et al., 2008) have reported 
the synergistic effect of the two important antidiabetic plant 
extracts, i.e., Azadirachta indica, and Vernonia amygdalina. 
These two studies are not enough as large numbers of 
antidiabetic plants have been documented in the literature. 
The synergistic effect is the combined effect of the 
constituents of two or more extracts, the effects being 
higher than if employed independently. Such a combination 
of extracts is in accordance with the formulation of herbal 
mixture where two or more plant extracts are combined. In 
such cases, some constituent may support the bioactive 
agent by enhancing its availability, decreasing metabolite 
formation and preventing its secretion (Rasoanaivo et al., 
2011). This idea has gained popularity among 
pharmacologists in the way of the formulation of herbal 
remedies containing various plant extracts. Therefore, 
assessment of the synergistic effect of these traditional 
antidiabetic plants may pave the way for combating the 
consequences of this metabolic disorder. 
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Several researchers have validated the antidiabetic 
potential of the reported plants through investigation of 
extracts and their bioactive constituents. These 
constituents include flavonoids and tannins isolated from 
Adiantum capillus veneris, Vitexin from Argyrolobium 
roseum, 3-O-galloylepicatechin and 3-O-galloylcatechin 
from Bergenia ciliata, vanillic acid and 4-hydroxybenzoic 
acid from Elaeagnus angustifolia, quinovic acid, quinovic 
acid-3β-O-β-D-glycopyranoside, quinovic acid-3β-O-β-D-
glucopyranosyl-(28→1)-β-D-glucopyranosyl ester and 
stigmasterol from Fagonia cretica, bergenin from Ficus 
racemosa, Isoorientin from Gentiana olivieri, flavonoids 
pectolinarigenin, pectolinarin from Kickxia ramosissima, 
stearoyl glucoside of ursolic acid, urs-12-en-3β-ol-28-oic 
acid 3β-D-glucopyranosyl-4′- Octadecanoate from Lantana 
camera, Mangiferin, from Mangifera indica, Charantin from 
Momordica charantia, Oleanolic acid from Olea europaea, 
polysaccharide from Opuntia dillenii, fructans and fructo-
oligosaccharides from Orchis latifolia, quercetin-3-O-α-D-
galactopyranoside from Rhododendron arboreum, Lupeol, 
12-oleanen-3-ol-3ß-acetate, stigmasterol and ß-sitosterol 
from Syzygium cumini and saponin from Tribulus terrestris. 
Some plants have been subjected to clinical trials. The 
gel added a diet of Aloe vera which was fed to 5,000 
angina pectoris patients for five years and which decreased 
triglycerides, total cholesterol, fasting and post-prandial 
BGL in diabetic patients, total lipid and increased HDL 
(Perez et al., 2007). In another clinical study, the juice of 
the same plant reduced BGL in 50 men and 22 women 
from 257.14±7.78 to 141.92±4.12 and showed significant 
decreases in triglyceride levels on day 42 (Yongchaiyudha 
et al., 1996). The fruit capsule of Citrullus colocynthis 
significantly decreased HbA1c and fasting BGL in 50 type II 
diabetic patients (Huseini et al., 2009). The aqueous extract 
of Momordica charantia and Eugenia jambolana for 15 
days substantially prevented hyperglycemia and 
hyperinsulinemia induced by a diet high in fructose in 10 
Type 2 diabetic patients (Waheed et al., 2007). 
Administration of two capsules (500 mg) of the aqueous 
extract of Fraxinus excelsior with 7 days break in 16 (50 g) 
glucose-induced postprandial hyperglycemic persons, 
showed a decrease in postprandial glucose levels and a 
significant increase in insulin secretion (Visen et al., 2009). 
This indicates that further clinical investigation of the 
traditionally used antidiabetic plants is imperative in order to 
provide a sound base for the development of antidiabetic 
agents. 
 
Toxicology 
Medicinal plants are considered safe due to their long 
historical use, but many serious side effects have been 
reported in the literature (Izzo, 2004; Whitton et al., 2003). 
These effects may be direct, allergic and due to the 
contamination or interactions with other drugs or herbs 
(Seth and Sharma, 2004). Information on the toxicity of 
medicinal plants is rarely documented in the 
ethnopharmacological surveys as is the case in Pakistan 
where nearly all such studies lack information on the toxic 
effects of medicinal plants. The correct use of traditional 
medicines can reduce the risks of toxicity. According to  
(Calixto, 2000) the idea that traditional medicinal products 
which come from natural sources are completely safe, is 
dangerously false. This current medicinal plants utilization 
is largely based on long-term clinical practices with little or 
no information on their effectiveness and safety (Zhu et al., 
2002). Several plants have been tested in the 
pharmacological studies for their toxicity.  Among these 
three plants, Artemisia herba-alba, Bombax ceiba were 
confirmed as toxic agents with obvious effects on 
behavior(Sathish Sekar et al., 2005). Therefore, the 
development of safe and effective products needs to be 
carefully observed in terms of their on-going development. 
It has become essential, therefore, to furnish the general 
public, including healthcare professionals, with adequate 
information to facilitate a better understanding of the risks 
associated with the use of these products and to ensure 
that all medicines are safe and of suitable quality. 
 
FUTURE PROSPECTS 
The pharmacological and clinical studies conducted 
around the globe have validated many of the reported 
plants for their potential use against the consequences of 
diabetes. This provides a prospect for further research in 
order to find novel antidiabetic agents, their potentials, 
mechanisms of action and synergistic effects for the 
eventual formulation of herbal mixtures and their 
combination with synthetic medicines. Such efforts will be 
more lucrative if their side effects are confirmed by careful 
clinical studies. Alongside these, new techniques must be 
employed to get excellent plant products in high amounts 
and to determine their potentials more accurately. 
 
CONCLUSION 
The current review comprises 185 plants traditionally 
used in the therapy of diabetes in various parts of Pakistan. 
The pharmacological studies indicate that nearly all of the 
investigated plants have shown antidiabetic activity and 
may serve as novel antidiabetic agents. Studies into the 
therapeutic efficacy and safety of these plants are also 
necessary because several plants have shown toxic 
effects. The increasing incidences of diabetes have turned 
the attention of researchers towards ways of discovering 
alternative therapies for diabetes. This research work may 
provide novel approaches for the development of plant-
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based herbal mixtures and antidiabetic agents from 
indigenous plant resources.  
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